Reconciled ClinicalTrials.gov v2 Protocol Specification
| Protocol Field | Verified Registry Value |
|---|---|
| NCT Identifier | NCT03969329 |
| Consolidated Lead Sponsor | Amgen |
| Therapeutic Condition Cohort | Endocrinology, Obesity, and Metabolic |
| Clinical Trial Phase | Phase III |
| Overall Recruitment Status | RECRUITING |
| Registered Enrollment | 24 participants (ESTIMATED) |
| Registered Start Date | 2019-12-20 |
| WhyStopped Classification | Not Stopped |
Named U.S. Hospital Clinical Research Sites
| Hospital Research Site | Location | Site Profile |
|---|---|---|
| Universitair Ziekenhuis Gent | Ghent, Belgium | Open Hospital Dossier -> |
| Fakultni nemocnice v Motole | Prague, Czechia | Open Hospital Dossier -> |
| Universitaetsklinikum Hamburg Eppendorf | Hamburg, Germany | Open Hospital Dossier -> |
| Medizinische Hochschule Hannover | Hanover, Germany | Open Hospital Dossier -> |
Related Filings Across Meru Platforms
Verified cross-ledger federal filings for Amgen across sibling Meru public-data platforms.
Search related sites and sponsors in the Interactive Directory, explore Endocrinology, Obesity, and Metabolic Benchmarks, or read the Healthcare Price & Patent Cliff Crosswalk.